Method for treatment of renal failure and occlusive lesion of blood vessels by administration of hepatocyte growth factor
US6869609B1 · kind B1 · utility
1Cited by
5References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 3, 1998 |
| Grant date | Mar 22, 2005 |
| Priority date | — |
| Expiry date | Dec 3, 2018 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P13/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention presents a preparation for continuous intravenous administration containing hepatocyte growth factor (HGF) as an active ingredient. The preparation for continuous administration of the invention is effective at a lower dose as compared with single or frequent bolus administration of HGF, and therefore side effects can be reduced.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.